Tag Archives: Business of Medicine

Innovative Medical Apparel Company Launches Men’s Lab Coats At Medica 2009 Conference

Medelita®, maker of breakthrough medical apparel, today announced the launch of its men’s lab coats, which are on display at Medica 2009, a leading international trade fair for the medical industry held in Dusseldorf, Germany. Medelita inaugurates its men’s collection with three varying lab coat styles, all named after distinguished figures in medicine: The Osler (44 in.), The Laennec (40 in.) and The Fleming (30 in.).

Men's Lab Coats

“Sophisticated, prestigious, innovative — these are words that medical professionals do not typically associate with lab coats,” said Lara Manchik, founder, Medelita.“But with the introduction of Medelita Men’s lab coats, male clinicians can now enjoy the same designer tailoring, high performance fabrics and upgrades that our female customers have raved about in our lab coats. The arrival of our men’s line is a natural evolution and we are thrilled to bring a product to market that’s long overdue.”

All Medelita lab coats are hand sewn in the U.S. using 100 percent pre-shrunk cotton, representing a significant improvement over traditional polyester/cotton blend lab coats with limited breathability. The lab coats feature a modern tailored fit, with finished inside seams and advanced fabric technology for unparalleled soil, stain, fluid and wrinkle resistance. While each style of Medelita Men’s lab coat is designed for a specific use, they are all available in contemporary menswear sizes 36-52.

The 44-inch Osler men’s lab coat is the modern version of the classic, full-length lab coat. Featuring five total pockets, including a concealed pocket for a PDA or Smartphone, the Osler lab coat is named after Sir William Osler, MD, CM, a Canadian physician, pathologist, educator, bibliophile, historian, and author, who is described as the Father of Modern Medicine.

The 40-inch Laennec lab coat is Medelita’s mid-length lab coat featuring abundant upgrades to this versatile physician lab coat. With a tailored, distinguished look and technically innovative features, this new men’s lab coat was named for René-Théophile-Hyacinthe Laennec, a French physician who invented the stethoscope in 1816, while working at the Hôpital Necker and pioneered its use in diagnosing various chest conditions.

The 30-inch Fleming lab coat is a hip-length lab coat, often called a “consultation” or “student” length lab coat. The Fleming is named after Sir Alexander Fleming, a Scottish biologist and pharmacologist who published many articles on bacteriology, immunology and chemotherapy. He is best-known for receiving the Nobel Peace Prize for the discovery of penicillin, which he shared with two colleagues.

About Medelita
Medelita has one purpose: to reinvent the way women and men of all healthcare professions present themselves at work by offering the highest quality, best fitting, and most comfortable medical apparel available, including women’s lab coats, men’s lab coats, embroidered lab coats and medical scrubs. Medelita caters to medical professionals who want their uniforms to embody the poise and confidence already displayed from within. For more information, visit our websites at http://www.medelita.com or http://www.medelita-mens.com, or call 877.987.7979.

Via EPR Network
More Healthcare press releases

New 28-Inch Student-Length Lab Coat Answers Customer Demand For Shorter Style And Is Available For Pre-Order

Medelita®, maker of breakthrough medical apparel, today introduced the new Elizabeth B. lab coat to its collection of high performance women’s lab coats. Shorter than traditional coats, the Elizabeth B. is 28 inches in length and falls just below the hip on a woman of average height. The new, shorter-length lab coat is available for pre-order and will be available to purchase online November 6, 2009.

“The introduction of the Elizabeth B. lab coat is a significant milestone for us in that it answers countless customer requests, expressing the need for a lab coat with modern styling, sensible performance fabric features and long-lasting durability,” said Lara Manchik, founder, Medelita. “We chose to name the coat in honor of Elizabeth Blackwell, the very first female medical school graduate who paved the way for women in field of medicine. This appellation also honors customers of Medelita who continue to make significant contributions in their respective medical professions.”

At the turn of the 19th century, female doctors did not exist. But Elizabeth Blackwell changed that with her inspiring life’s work. Education played an important role for Blackwell, whose father moved the family from England to the U.S. Motivated by the desire to fill the unmet needs of women who preferred to consult with a female physician, Blackwell eventually sought a formal education during a time when medical schools simply did not allow women. Her application to the Geneva Medical College in New York was inadvertently accepted because students and the administration thought it was a practical joke.

Eventually, Blackwell’s persistence won her respect, admiration and the first U.S. medical degree awarded to a woman in 1849; however, she was barred from practicing in hospitals and set up a practice out of her own home. Among Blackwell’s many achievements was the establishment of women’s medical schools in the U.S. and in England. The educational institutions were the culmination of plans co-developed with Florence Nightengale, whom she met during the Civil War. Well into her later years, Blackwell continued to inspire and encourage women to study medicine. Today, women represent more than half of the students pursuing some form of medical education.

The Medelita Elizabeth B. lab coat is designed for those medical professionals who prefer technical advancements – not only in their clothing but also in their lifestyle. The fluid resistant lab coat is treated with Advanced Dual Action Teflon® fabric protector, which allows the fabric to repel and release stains, including blood, while maintaining a clean and crisp, polished appearance. Tailored for a feminine yet professional shape, the coats are sewn in the U.S. and feature the highest quality workmanship available in a medical uniform. Modern styling includes rounded lapels with complimentary pocket detailing, clean finishing of all seams, and a hidden inside pocket for transporting handheld devices and other useful medical tools.

Also called a consultation lab coat, the 28 inch lab coat is worn by students across numerous medical professions — medical school, dental school, physician assistant school — as well as by those medical professionals who simply prefer a hip length lab coat. Although the length is often a designation of a student, in some settings, the shorter coat is preferred or even required.

The new lab coat joins the Medelita collection of women’s lab coats, which range from the original, full-length Callia lab coat (38 in.), the Ellody (34 in.), to the Estie (38 in.) and Sophia (34 in.), all of which can be custom embroidered with name, title, and profession as preferred. For more information on the Elizabeth B. lab coat and all Medelita products, please visit www.medelita.com.

Via EPR Network
More Healthcare press releases

Medelita Celebrates National Nurse Practitioner Week

Medelita®, maker of breakthrough medical apparel, celebrates National Nurse Practitioner Week this November 8 through 14. Nurse practitioners (NPs) are advanced practice nurses who provide high-quality healthcare services similar to those of a doctor. They diagnose and treat a wide range of health problems, and even prescribe medication. This year, nurse practitioners are celebrated for providing “125,000 solutions to the primary care shortage.”

“Nurse practitioners play a critical role in our healthcare system, providing much needed care that encompasses disease diagnosis and treatment, health education and helping patients to make wise choices and to become better advocates of their own health,” said Lara Manchik, PA-C and founder, Medelita. “Medelita is proud to be a partner to NPs, who combine strengths f r o m nursing and medicine to provide a holistic approach to personalized patient care.”

Most nurse practitioners have advanced degrees, such as master’s degrees, and training beyond their registered nurse credentials. Many even have doctorates in their areas of specialty. Since 1965, NPs have been practicing in all types of settings including clinics, hospitals, private physician or nurse practitioner offices, schools, urgent cares, colleges and public health offices, to name a few.

Every day, nurse practitioners are making a difference in the lives of patients and they are advancing the role of women in the healthcare professions. Medelita honors NPs this week and throughout the year, through its “Celebrating Women in Healthcare” campaign showcasing the talents, devotion and accomplishments of women all across the nation, just like Secor. The women selected for “Celebrating Women in Healthcare” each receive a lab coat or scrubs of their choice and are featured on the Medelita web site. Nominations that include photos and detailed descriptions of professional and personal accomplishments can be emailed to celebrating.women@medelita.com.

About Medelita
Medelita has one purpose: to reinvent the way women of all healthcare professions present themselves at work by offering the highest quality, best fitting, and most comfortable medical apparel available, including lab coats, embroidered lab coats and women’s medical scrubs. Medelita caters to professional women who want their uniforms to embody the poise and confidence already displayed f r o m within. For more information, visit our website at http://www.medelita.com or call 877.987.7979.

Via EPR Network
More Healthcare press releases

Catalent Expands Capabilities In Testing For Melamine In Food And Medicinal Products

At a time when melamine-contamination has received global attention, Catalent Pharma Solutions continues its legacy of innovation by rapidly developing new FDA guidance-compliant tests for trace amounts of key contaminants in food and medicine. Incidents of melamine contamination in milk products, baby formula, dairy and non-dairy products manufactured in China have been widely reported, leading to product recalls and increased inspections by the FDA.

The current good manufacturing practice (CGMP) regulations require that all components (i.e. ingredients or raw materials) be tested before they are released for use in the manufacture or preparation of drug products (21 CFR 211.84). It is critical that all manufacturers determine whether they are using an at risk component for melamine contamination to manufacture or prepare a drug product.

In response to the FDA’s new guidance titled “Pharmaceutical Components at Risk for Melamine Contamination,” Catalent has successfully qualified a method for determining if suspect excipients are contamination-free to within 2.5 parts per million. The method is based on that provided by the FDA (Laboratory Information Bulletin No. 4423 “GC-MS Screen for the Presence of Melamine, Ammeline, Ammelide, and Cyanuric Acid”).

Catalent is now able to provide its customers successfully qualified and validated limits tests for trace levels of melamine, ammeline, ammelide, and cyanuric acid in lactose.

Melamine is a compound made of carbon, nitrogen and hydrogen and is typically combined with formaldehyde to produce a durable and moldable plastic that is fire and heat resistant. Trace amounts of melamine have recently been discovered to be toxic to dogs, cats, pigs, and chickens by veterinary scientists after kidney or renal failure occurred due to their food being contaminated with the chemical.

“Catalent is proud to have satisfied the demanding regulatory standards the US FDA has provided for detecting melamine,” said Kent Payne, Vice President and General Manager of Catalent’s Respiratory, Analytical and Biotechnology Services business. “Detecting trace levels of melamine in food and medicinal products at these levels is a challenging process, but is key to help avoid future public health crises. In order to support this critical public health need, Catalent can expedite this testing and provide results within 48 hours from receipt of samples

Fore more information on the US FDA guidelines, please visit:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm176088.htm.

About Catalent
Headquartered in Somerset, New Jersey, Catalent is one of the leading providers of advanced dose form and packaging technologies, and development, manufacturing, packaging and printing services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,500 at 30 facilities worldwide and in fiscal 2009 generated more than $1.6 billion of annual revenue. For more information, visit www.catalent.com.

Via EPR Network
More Healthcare press releases

Catalent To Present Webinar On Stabilities Studies In Pharmaceutical Development

Catalent Pharma Solutions will host a free Webinar featuring Senior Manager, Wei Pan, Ph.D. RAC and Kathy Waddle, Director, Stability QC Biology. The one-hour Webinar will cover stability studies as a critical part of the drug development process and the vital role they play for drug product marketing approval. The Webinar, titled “Stability Studies in Pharmaceutical Development,” will be held on Friday, November 20, 2009 at 2 p.m. (EST). To register for the Webinar please visit: https://www2.gotomeeting.com/register/280747146.

The presentation will address the principles and practices of stability studies in the drug development process. Pan and Waddle will discuss the framework of the FDA cGMP guidelines as expressed in 21CFR211. Additionally, the Webinar will provide a comprehensive review of ICH and WHO stability guidelines by discussing the strategy used in stability protocols designed to support global registration.

Stability studies are conducted at all phases of the drug development cycle for different purposes with the ultimate goal of having a stable product on the market. During development, stability studies are conducted to support the formulation development and safety and efficacy claims of investigational new drugs. At registration, they are conducted to ascertain the quality and shelf-life of the drug product in their intended packaging configuration. After approval, the stability studies are conducted to ensure the quality of production and to support site or other changes to the product.

For more information on Catalent’s broad range of drug and biologic development services, go to www.catalent.com/development.

Via EPR Network
More Healthcare press releases

Little Sprout Imaging Was Pleased To Be Included In This Months Issue Of Angie’s List Health

Martha Morgan, the Founder of Little Sprout Imaging, was invited to respond to the controversy surrounding the industry and the recent ban of non-medical ultrasounds in the State of Connecticut. Rounding out the “Ask the Experts” panel is Dr. Jacques S. Abramowicz.

Little Sprout Imaging Was Pleased To Be Included In This Months Issue Of Angie’s List Health

Morgan admits that the industry has a less than desirable reputation. Earlier this decade, the FDA and AIUM expressed concern about the use of a medical device by untrained personnel. Yet, centers continue to open across the country with the business owner having learned how to operate the ultrasound machine in 2 days. Pregnant women assume that their state or the federal government oversees the industry. If Moms-to-be understood that 90% of the free-standing 3D centers were operated by laypeople rather than trained professionals, they would seek out the true professionals and consumer demand would settle the industry controversy. If we, as an industry, do not self-regulate; the states may very well legislate us all out of business. The State of Connecticut did exactly that effective, July 1, 2009.

To view the entire article in Angie’s List Health, go to:
Angie’s List Health, October 2009 Issue

Little Sprout Imaging has provided 3D / 4D ultrasounds in Maryland since 2004. Their service model includes medically trained Sonographers and physician oversight. Their high-standards take into account the FDA and AIUM concerns. This distinction earned them the 2006 Smart Woman Bravo! Business Achievement Award as well as the label “Mom and Baby Friendly” in the Greater-Baltimore region. In addition to their responsible business practices, technologically they are a leader in the industry. Little Sprout Imaging introduced webcast ultrasounds to the industry in 2006. Their webcast service; called SproutCast, is offered LIVE and OnDemand.

To sign the Little Sprout Imaging petition to keep 3D ultrasounds elective in the State of Maryland, go to: LittleSproutImaging.com Click on sign the petition.

Via EPR Network
More Healthcare press releases

Senior Director of Biotechnology at Catalent To Present Industry Conferences

Ana T. Menendez, Ph.D., Senior Director of Biotechnology at Catalent Pharma Solutions, will be delivering workshops this October at two industry conferences.

The first will be a pre-conference workshop at Cambridge Health Institute’s Immunogenicity Summit. The event will take place in Philadelphia on Monday, October 26, 2009. The interactive workshop, titled “Technical Advice on Assay Development,” will begin at 8:30 a.m. and will enable attendees to develop an immunogenicity pre-clinical and clinical testing protocol for a therapeutic protein.

The second presentation by Menendez will be a seminar at San Francisco’s Biologicals to Devices (B2G) conference on October 27. The workshop will be called “Effective transfer of Complex Biological Methods in the GMP Environment.”

As part of Catalent’s Development and Clinical Services Segment, Dr. Menendez is responsible for the release tests required to verify the functionality and purity of biotechnology products and the complex processes involved in their manufacture. Menendez implemented biotesting at Catalent and currently leads the following laboratories at the North Carolina Research Triangle Park facility: Cellular Technologies, Molecular Technologies, Virology and Analytical Biosafety. The expertise of the department ranges from proteins (i.e., monoclonal antibodies, enzymes, growth factors) to therapeutic viruses, bacterial vaccines and aptamers. Menenedez is an international instructor on bioassay development and validation and a frequent speaker at biopharmaceutical conferences.

For more information on Catalent`s broad range of drug and biologic development services, go to www.catalent.com/development.

Via EPR Network
More Healthcare press releases

Medelita Joins AAPA in Celebrating National PA Week

Medelita®, makers of innovative high-quality scrub sets and lab coats for women in health care who excel in their profession and take pride in their appearance, joins the American Academy of Physician Assistants (AAPA) in celebrating National PA Week, October 6 – 12.

“National PA Week provides us the perfect opportunity to raise awareness of the central role PAs have in shaping the future of health care in this country, and across the world,” says Medelita founder Lara Manchik, who brings a decade of experience as a PA to her breakthrough line of medical apparel. “We’re honored to join AAPA in celebrating National PA Week and the professionals who deserve this recognition. AAPA is doing an outstanding job communicating the role of PAs in transforming health care — not just on the floor and by the patient’s bedside, but in our laws and legislation.”

Manchik points out that PAs have always responded to the changing needs of patient care. Launched in 1967 at Duke University Medical Center, the first PA program was developed to utilize the skills of returning Vietnam medics and fill a need for quality health care when and where it is needed most. Since then, PAs have continued to make cost-effective, quality health care accessible to more people who might otherwise have limited, or no, access.

Today, you’ll find PAs providing not only primary care, but also working with physicians across a spectrum of medical specialties. Says Manchik, ”Patients and physicians alike are recognizing the tremendous value that PAs, with their advanced training and knowledge, bring to patient care. They assume many of the same responsibilities of doctors, keep costs in check, and spend time with patients to completely understand their needs and goals. National PA Week allows us to acknowledge this contribution.”

During this year’s National PA Week, the AAPA is emphasizing the leading advocacy position PAs share in the current health care debate. Through grassroots efforts and awareness-raising campaigns, AAPA and its members are making sure legislators include PAs in the strategy to increase access to quality, affordable health care.

“National PA Week brings much deserved attention to these dedicated, extraordinary professionals,” adds Manchik. “Medelita applauds the AAPA and its members for their tremendous efforts and commitment to reform health care. We’re proud to provide PAs quality lab coats and scrub sets that reflect their exceptional dedication and professionalism.”

About Medelita
Medelita has one purpose: to reinvent the way women of all health care professions present themselves at work by offering the highest quality, best fitting, and most comfortable medical apparel available, including scrubs and women’s lab coats. Medelita caters to professional women who want their uniforms to embody the poise and confidence already displayed from within. For more information, visit www.medelita.comor call (877) 987-7979.

Via EPR Network
More Healthcare press releases

Health Care Industry Leader Joins Health by Design Executive Team

Health by Design of San Antonio, TX, a leading provider of health care services to businesses and individuals, has recently appointed Omar Rodríguez as Executive Vice President, Corporate Development and Strategic Planning. With nearly 30 years in the health care arena, Rodríguez assumes a newly created role to help Health by Design reach more companies with its unique approach to medical care. His first area of concentration will be to further develop the Texas market.

“Omar is an outstanding individual with a wealth of experience and knowledge both in managing companies as President and CEO and administering health care benefits for self-insured companies. As we look to expand our role in helping companies provide quality medical care to their employees through prevention, knowledge and personal care, Omar will be able to bring valuable industry insight to better serve our clients and mission,” said Health by Design CEO and Medical Director Dr. James Ogletree. Health by Design Management President Barney Randol also noted that through fiscal responsibility and client growth and retention Health by Design has had solid year over year revenue growth.

About Health by Design
Founded in 1982 by Dr. David Player in San Antonio, TX, Health by Design successfully blends medical care, physician knowledge and personalized care to provide quality health care for corporations, small businesses and individuals. Utilizing a long practiced unique approach to medical care, Health by Design physicians share a common philosophy of prevention, education and wellness. They perform comprehensive evaluations of a patient’s current physical condition and then develop a program that maximizes their health and lifestyle, while helping employers reduce health care costs and increase productivity. For more information, visit: www.hbdus.com.

Via EPR Network
More Healthcare press releases

Tier 2 Consulting Helps Healthlogistics Deliver Online Catalogue and Contract Price Data to the UK NHS

Healthlogistics.co.uk Ltd, the UK’s leading NHS e-procurement consultancy, has recently announced that ten leading NHS acute Trusts are now piloting its innovative online supplier catalogue and contract data system. Based on hybris and JEE technology, and customised and implemented by Tier 2 Consulting, HL-hybris provides a single source of reference for catalogue, contract and contract price data. The next phase of development of the system is now about to begin.

healthlogistics.jpg (169×111)

Tier 2 Consulting announced today that the next phase of the development of Healthlogistics’ HL-hybris catalogue and contract management system is about to begin. This will deliver outstanding search, contract generation and dashboard functionality for both Trusts and suppliers.

As part of the roll-out, some 900 suppliers working with these ten Trusts, including Kings College Hospital, Royal Brompton & Harefield and Sheffield Teaching Hospitals Foundation Trusts, are now or will soon be providing filtered product, price and contract data via their dedicated web portal where they can securely and confidentially access data specific to them.

These acute and acute Foundation Trusts are pioneering the adoption of private-sector best practices and are keen to achieve the cost benefits of efficient supply chain management and data synchronicity.

Commenting on the continuing development of HL-hybris, Healthlogistics’ Director Peter Elwin said, “As a hybris Premium Business Partner, Tier 2 Consulting has a proven track record in system integration and configuration. As we continue to enhance the platform, and as each new Trust adopts the HL-hybris solution, we benefit from the technical expertise of Tier 2 to help us bed-in new Trusts and support this initiative over the long term. I’m confident that we have the best team in place to do that.”

Andy Kennedy, Director at Tier 2 Consulting, commented: “We were delighted to be chosen in 2008 by Healthlogistics to deliver the technical aspects of their HL-hybris offering, and are excited about the many exciting further enhancements that are planned over the coming year. The combination of Healthlogistics’ undoubted expertise in the field of NHS e-procurement, Tier 2’s technical experience and the extensive functionality of the core hybris system has resulted in a truly innovative platform”.

Via EPR Network
More Healthcare press releases

Co-operative Pharmacy Offers Free Hearing Tests

The Co-Operative Pharmacy has pledged to provide free hearing tests at a number of their branches throughout the UK. The proposal is a part of a new audiology service being trialled in selected branches in the UK as an effort to help those with hearing problems get the treatment they need.

Many UK patients do not notice any deterioration in their hearing and it is hoped that by having these sessions made available that the Co-Operative Pharmacy can help identify who may need a hearing aid.

If after taking part in the free hearing test that the patient is identified as having hearing difficulties then they will then be offered advice on purchasing a hearing aid, either privately or being referred to a GP if they wish to get one via the National Health Service.

For patients opting to purchase privately they will be able to have their hearing aid fitted within 3 weeks and free follow up appointments to make sure everything is fine at their pharmacy.

The Co-Operative aims to have the service in 80 of its branches nationwide with fully qualified audiologists available twice a month for consultations by September 2009.

Via EPR Network
More Healthcare press releases

Swine Flu Could Trigger Boom In Remote Diagnosis

Lloydspharmacy has revealed a new report that suggests the government’s use of the internet and call centres to deal with the swine flu pandemic could pave the way for a rapid growth in remote diagnosis and prescriptions. This was just one of the conclusions found in the report by the Future Foundation.

Judith Kleine Holthause, the report’s lead author, said:”Despite its clinical shortcomings, the use of the internet and call centres for diagnosing swine flu and distributing medication demonstrates that remote diagnosis can be an efficient way of dealing with certain conditions.”

The Future Foundation forecasts that 37% of people will be using the web for medical information by 2020 (up from 14% in 2009) and that a variety of social and economic factors will lead to a substantial market for online diagnosis and prescriptions in the future.

The report, commissioned by Lloydspharmacy, coincides with the roll-out of ‘virtual GPs’ into 300 of the chain’s pharmacies. Lloydspharmacy has pioneered online diagnosis and prescription.

Now the chain has innovated again by allowing customers to walk into a pharmacy, consult with a doctor from a computer terminal and walk out with their prescriptions a few minutes later.

Andy Murdock, pharmacy relations and governance director of Lloydspharmacy, said: “The face to face consultation will remain at the heart of primary care, but for an increasing array of conditions, remote services provide a viable alternative.

“Right now these include lifestyle conditions such as impotence and hair loss, embarrassing conditions such as STIs, contraception and certain minor ailments such as cystitis. But the list could expand considerably in the future.”

However the report’s authors warn that regulation will be critical if privately run diagnosis and prescription services are to grow. At present only one online doctor service is registered with the Care Quality Commission explicitly to manage patients remotely. That service, Dr Thom, also provides the GP component of the Lloydspharmacy service.

There is no question that consumers are receptive to the concept. Forty eight per cent of respondents to a poll conducted for the Future Foundation said they were interested in online diagnosis and 56% said they were interested in online prescriptions.

Holthaus added: “In certain areas consumers welcome regulation. Concerns about counterfeit medicines, bogus doctors and commercial motivations will inevitably act as a brake on consumer confidence in remote diagnosis services. We believe that more regulation, monitoring and control will be crucial to the further development of this market.

“There are strong arguments for why the NHS might embrace remote diagnosis as a complementary method to ensure sufficient delivery of satisfactory health care in the future. If regulated and monitored appropriately remote diagnoses and prescriptions could benefit the healthcare system in similar ways as remote services have helped the banking system.”

The Lloydspharmacy Online Doctor service is run in conjunction with online health experts Dr Thom, who adhere to the General Medical Council’s guidelines on remote prescribing. Patients log on for an online questionnaire-based consultation with a GP. If clinically appropriate the GP writes a prescription and the treatment is dispensed by post for next day delivery.

Via EPR Network
More Healthcare press releases

Acurest – The First Non-Invasive, Drug-Free, Predictable Solution For Snoring And Sleep-Related Problems

“Acurestâ„¢ finger wraps provide the first non-invasive, drug-free, predictable solution for snoring and Sleep-Related Problems“, says Dr. Gerald Smith, CEO of the International Center for Nutritional Research and author of several books including Headaches Aren’t Forever and Alternative Treatments For Conquering Chronic Pain.

Acurest

The inventor of the Acurest™ Anti-Snoring Device is Eula Mae Pollard – a reflex therapist from Mississippi, United State. Ms. Pollard discovered, in April 2006, that continuous massage to the first joints of the thumbs and index fingers could prevent snoring and other sleep related problems.

This discovery came after twenty-four years of study and the utilization of a simple therapy that helped her and others recover from disabling injuries.

In 1980, Eula Mae Pollard suffered a severe whiplash injury which gave rise to a rare arthritis of the spine and fibromyalgia, Told by a rheumatologist that she would have to take medication for the rest of her life, she worried that this would be no cure for the underlying cause of her condition and decided to research alternative options.

One day as she sat crying, her son handed her a book on reflex therapy, that her grandmother had left her. He said “Here, Mother, read this, it will help you”. She had glanced through this book before and thought it sounded to good to be true, but her son’s words, “It will help you”, touched her deeply.

Eula Mae propped the book up on a pillow as she was unable to hold it up, and could only read two or three chapters at a time because her severe pain and stiffness seemed to distort her concentration and her ability to comprehend. As she was reading she decided out of desperation to prove or disprove whether reflex therapy could relieve pain. In one of the chapters she learned how to stop throat pain, and it so happened that one week later she woke up with a severe sore throat.

Eula Mae considered the sore throat a great opportunity to test reflex therapy. She massaged her right hand as directed in the book, and the pain on the right side of her throat disappeared. She repeated the massage on my left hand, and got the same pain relief on the left side of her throat. In five minutes her throat was completely pain-free.

Eula Mae felt as if God had shown her this, and she thanked him for it immediately.

Her throat pain returned in two hours, so she repeated the therapy every two hours that day, and had less pain every time it returned. The next morning she was pain free.

This proof gave her new hope in finding a solution for her overall body pain and stiffness. She continued to study the book, and continued to massage her hands and fingers in a certain way. Her pain and stiffness began to diminish as days went by. She found that she couldn’t miss a once-daily treatment, and soon regained her health in every respect and started to give reflex treatments to family and friends.

This is what eventualluy gave birth to Acurestâ„¢ (Snoring Remedy), a solution to the age-old problem of snoring.

She named the finger wraps Acurest™, because they prevent Snoring and other sleep-related problems. Acurest™ allows one to get accurate rest, when they sleep.

Via EPR Network
More Healthcare press releases

Customers Give Medelita Lab Coats and Scrubs Rave Reviews

Medelita®, maker of breakthrough medical scrubs and lab coats for female clinicians, was founded on the premise that quality medical apparel should be both beautiful in appearance and high in performance. At a time when unisex medical uniforms dominated the market, a woman’s only choice was to shop on price; today, that paradigm has changed and the value of a garment is defined by a high level of product and customer satisfaction, as reflected in accolades from loyal Medelita customers.

Medelita Lab Coats

“I received my new lab coat today and it is beautiful finally, a lab coat that doesn’t look like I’m wearing a big white bag and feel like sandpaper,” said Mary Beth H., PA-C, of Loma Linda, Calif. “The workmanship is so nice. It looks like it was custom made and fitted for me. The detailing gives it such a clean, superior look. Thank you for making a great product!

Considered to be utilitarian by some, the frumpy, unisex scrubs and lab coats provided by hospitals for female employees fail to deliver the confidence and composure that professional attire should convey. Medelita strives to meet the needs of women in healthcare.

“I saw the write up about your coats in the e-mail from AMWA,” according to Desiree C, physician from Dover, Mass. “I never thought about getting my own coats before (for over 30 years). I’ve always worn the thin, horrible ones the hospital provides. I’m looking forward to receiving yours.”

“I must commend Medelita for its outstanding commitment to serving health professionals, for having beautiful attire is an important component of delivering effective medical care,” said Linda S., a satisfied customer from Westbury, NY. I look forward to ordering more items from the company!”

Many companies touting designer lab coats overlook performance and functionality for the sake of appearance, but Medelita addresses both with high performance fabrics and feminine tailoring.

“I purchased a lab coat from [Medelita] at the CAPA conference this year. Just wanted to let you know that I LOVE IT! I get compliments all the time on how tailored and professional it looks, said Tiffany H., PA-C from Sacramento, Calif. “I’ve gotten blood on it more than once and it beautifully rolls right off. And I love that I can wash it, throw it in the dryer and it comes out looking like the day I bought it, stainless (and no ring around the collar which has been a problem with previous white coats over time), and without wrinkles. Thanks for making such a great product!”

For the first time ever, women in clinical settings are rewarded with fit, functionality and form in a product that is a staple in their wardrobe but that wears like a custom-made outfit.

“You can be assured I will be passing this along to friends, colleagues and family (mom and sis are also doctors!),” said Silddly A. MD from Doral, Fla. “This is exactly what we have all been waiting for! As you said, the lab coat is our ‘suit’, and it should look the best. The feminine but classic look is perfect.”

“I am SO happy with the scrubs. I wore them for the first part of the photo shoot, and I think they looked marvelous,” stated Margaret A., PA-C from Palo Alto, Calif., who won an award in her field. “The material is wonderful, and I never thought scrubs could be so flattering. I love the shape. I am so glad I bought the items. I’d been thinking about it, and then that award was the impetus for a treat. And a treat they are! Thank you so much for your excellent customer service.”

In addition to women working in healthcare, Medelita lab coats are worn and appreciated by those in academia and other laboratory settings, who need a garment that commands respect as effectively as it repels fluids.

“Let me just tell you how pleased I am with the coat. It is even nicer and better than I could have expected. The quality, durability, everything about it down to the embroidery is excellent,” remarked Ashley T., PhD in Toxicology from Raleigh, NC. “Frankly I just cannot put into words my happiness when I see how liquid and other materials that normally soak right through my old lab coats just seem to bounce off of your lab coats, it is so wonderful that I just cannot bring myself to put the old ones back on while my new one is being laundered!”

“I do love my Medelita scrubs,” said Ellen S., MPAS, PA-C from Houston, TX. “A patient spilt his pancake syrup on me the other day and I just went to the sink and it washed right off. It dried just as quick. Awesome!”

Women are seeking out Medelita’s practical and stylish solution to perfunctory unisex medical uniforms and are delighted to receive them as gifts, as described in this customer’s experience purchasing embroidered lab coats.

Made from 100 percent high-denier cotton, the Medelita lab coat is designed specifically for women with a focus on fit and function. The fluid resistant lab coats are treated with Advanced Dual Action Teflon® fabric protector, which allows fabric to repel and release stains. Tailored for a feminine shape, the coats feature traditional side slits, French finish inside seams and hidden inside pockets that are great for carrying handheld devices and mobile phones.

About Medelita
Medelita has one purpose: to reinvent the way women of all healthcare professions present themselves at work by offering the highest quality, best fitting, and most comfortable medical apparel available, including lab coats, women’s lab coats and women’s scrubs.

Via EPR Network
More Healthcare press releases

Established Ink Stain Remover Is A Must-Have For Clinical Professionals Wearing White Lab Coats

Medelita®, maker of breakthrough medical scrubs and lab coats for female clinicians, today announced the addition of the breakthrough stain remover Amodex® to its extensive line of products. Internationally known as one of the best products available for the removal of ink stains, Amodex can also be used in the removal of food stains, blood, and makeup from clothing, furniture and other household surfaces.

“Worn in hospitals and in clinical setting, white lab coats inherently get dirty and are subject to permanent damage, if stains cannot be removed. Ink stains are a common culprit as pens tend to leak in pockets and the dominant sleeve tends to pick up ink while a clinician writes,” said Lara Manchik, founder, Medelita. “Even with the most advanced fabrics and treatments, ink stains are still a problem. That’s why we are pleased to add Amodex Ink and Stain Remover to our line of products. After much research, we have found that Amodex is the best product to get pesky ink stains out of our lab coats.”

Amodex is an eco-friendly, non-toxic lanolin cream that was specially developed to remove ink stains from fabrics, skin and other surfaces. Amodex is the only liquid cream stain fighting formula that is not a solvent but instead a soap, which is non-corrosive and won’t harm skin or clothing. A versatile product, Amodex not only works wonders on ink, but also effectively removes stains that clinicians may run into on a daily basis such as blood, iodine, coffee, tea, chocolate, lipstick, or just about anything else that would leave a seemingly permanent stain.

Trusted by customers, Amodex is rated number one by a leading consumer magazine. Popular ink makers have lab tested and recommend Amodex for the removal of unwanted marks on fabrics and skin. Medelita has independently tested Amodex and found that it is the best product on the market for removing stains from its high performance lab coats and scrubs.

Made from 100 percent high-denier cotton, the Medelita lab coat is designed specifically for women with a focus on fit and function. The fluid resistant lab coats are treated with Advanced Dual Action Teflon® fabric protector, which allows fabric to repel and release stains. Tailored for a feminine shape, the coats feature traditional side slits, French finish inside seams and hidden inside pockets that are great for carrying handheld devices and mobile phones.

In addition to high quality lab coats, Medelita provides a line of performance women’s healthcare apparel, including clinician scrubs and nursing scrubs, which are available for purchase at www.medelita.com.

Via EPR Network
More Healthcare press releases

Introducing The New ‘Mother To Be’ Range, By Celebrity Colourist Louise Galvin

Fantastic news for all those new mothers or mothers to be: Louise Galvin celebrity colourist has created a complete natural hair care range dedicated to women, pre, during and post pregnancy. This range is said to have “…the most natural and environmentally friendly hair products on the market…” (Plum Sykes, novelist and contributing editor, Vogue Magazine). As well as offsetting any carbon emissions caused via manufacturing by investing in the Carbon Neutral Company, the range is totally natural. Using solely natural or naturally-derived ingredients like essential oils, natural extracts and vegetable-derived moisturising and conditioning ingredients, there isn’t a sign of any harmful sulphates, parabens, silicone, petrochemicals, synthetic fragrances and polymers in the new mother to be haircare line.

The new ‘Mother To Be’ range was inspired by Louise Galvin’s own recent pregnancy. While pregnant, Louise found she needed help in retaining her hair’s shine and vitality and assistance in creating volume and root lift. During pregnancy, women can be a lot more sensitive to smells than they usually are, consequently the citrus aromatherapy oils frequently used in Louise Galvin’s other products and ranges can be overpowering in the early days of pregnancy. Louise set about creating a hair care range that was both fragrance-free and extremely enriching, giving pregnant women an extra helping hand. The result is ‘Mother To Be’.

What’s more, Louise like other women during their pregnancies became extra conscious about safety: skin is our largest organ and anything we put on it (from body wash to shampoo) is absorbed into the bloodstream and can find its way to the growing foetus through the placenta. After pregnancy, these same chemicals are retained within the body, in particular in breast milk. Many popular cosmetics are made with harmful or damaging chemicals, unfortunately these chemicals been linked to birth defects and health problems. Nevertheless, pregnant women or those that are nursing a new born can rest reassured that all ‘Mother to Be’ and Sacred Locks products are free from any harmful or nasty chemicals.

Louise Galvin has pledged to personally help raise vital funds for the charity. So check out her new ‘mother to be’ eco-friendly, Sacred Locks range online visit:http://www.louisegalvin.com and give a little back.

Via EPR Network
More Healthcare press releases

The World’s First Dry-On-Contact H1N1 Sanitising Spray

A sanitising spray that kills 99.99% of Viruses, Bacteria and Germs is now available for purchase in the UK. The SaniGuard wipes, spray and fogger products were invented by David Morgan, president of DEM Technology in the United States.. After patenting the product he was awarded EPA registration for its use on food contact surfaces in 1996.

The World's First Dry-On-Contact H1N1 Sanitising Spray

One benefit of the spray is that there is no “wet dwell” time, meaning that users don’t need to wipe the product away prior to it being effective. According to US laboratory reports, the product kills 99.99% of germs in 30-45 seconds. It also exceeds the requirements of EN1276 in Europe.

Jim Taylor, formerly president of Smith & Nephew and now CEO of Saniguard International, based in Chorley, Lancashire, said: “SaniGuard contains a unique configuration of quarternary ammonium compounds (QUATS) and other proprietary components, which allow for the elimination of microbes that regular QUATS alone cannot kill.”

The dry-on-contact spray can be used in between regular cleaning on “hot spot” areas such as telephones, computer keyboards, light switches, door knobs and other areas that are frequently used and rarely cleaned. SaniGuard leaves no film or moisture on surfaces.

The spray is effective against Swine Flu, MRSA, HIV-1, herpes, herpes simplex 1 and 2, salmonella typhi, staphylococcus aureus, streptococcus epidermidis and pseudomonas aerginosa and fungi such as trichophyton interdigitolo (Athlete’s foot).

MisterSterile.com also offers the Total Release Fogger in a single-release aerosol, which is claimed to sanitise an entire room with the press of a button within 15-20 minutes. The product is available in small room (155ft²) and large room (625ft²) sizes.

The company says this product is safe for all surfaces and helps to stop the transmission of germs in high traffic areas such as lobbies, waiting rooms, hospital wards, GP surgeries and patient care facilities.

Anti-Bacterial, Anti-Virus Swine Flu prevention products from MisterSterile.com ‘Mr Sterile.com’ is authorised by SaniGuard International and have launched their new website to service the explosive demand for anti-bacterial, anti-virus products.

Via EPR Network
More Healthcare press releases

Lloydspharmacy Is To Become The First Major Healthcare Brand To Supply Tamiflu Online

Customers can now buy Tamiflu via the Lloydspharmacy Online Doctor service. “We are playing as full a role as possible in the distribution of Tamiflu to NHS patients,” said Andy Murdock, Governance and Pharmacy Relations Director of Lloydspharmacy, “but it is clear that there is a significant demand for private prescriptions of the drug.

Supply Tamiflu Online

“We have decided to become the first recognised healthcare brand to sell Tamiflu online in advance of need so that people who want to buy the treatment can get it from a reputable online source which they can trust to dispense Tamiflu.”

Lloydspharmacy’s Online Doctor service is run in partnership with online health experts Dr Thom, the only online doctor to be regulated by the Care Quality Commission* specifically to prescribe medicines online.

Packs of 10 x 75mg Tamiflu will be available via the online pharmacy. All medicines will be dispatched using Royal Mail Special Delivery for delivery the next working day.

“Anyone displaying symptoms of swine flu, would be advised to call the NHS service appropriate to their area,” said Andy Murdock. “The Lloydspharmacy service is for people who want to ensure they have Tamiflu available if and when they need it and for people who will be travelling abroad at some point in the future.

“In the information sent out with every Tamiflu order Lloydspharmacy doctors will explain the symptoms people should look out for and the circumstances under which they should begin treatment.”

Lloydspharmacy has pioneered the development of online diagnosis and prescriptions. The Lloydspharmacy Online Doctor service is expanding and already offers treatments for impotence, hair loss and cystitis plus oral contraceptives, sexual health tests and travel medications.

About Lloydspharmacy
Lloydspharmacy has around 1700 pharmacies across the UK. These are based predominantly in community and health centre locations. The company employs over 16,000 staff and dispenses over 145 million prescription items annually. Lloydspharmacy is the trading name of Lloydspharmacy Ltd, a wholly owned subsidiary of Celesio AG based in Stuttgart. Celesio is the leading pharmaceutical distribution company in Europe and is represented in 16 countries. With its three divisions, Patient and Consumer Solutions, Pharmacy Solutions and Manufacturer Solutions, the group covers the entire scope of pharmaceutical trade and pharmaceutical-related services.

Via EPR Network
More Healthcare press releases

The U.S. Department Of Commerce Selects Medelita To Exhibit At Medica 2009

Medelita®, maker of breakthrough scrubs and lab coats for female clinicians, today announced that it has been selected by the United States Department of Commerce to participate in Medica 2009, a leading international trade fair for the medical industry, which will be held in Dusseldorf, Germany, November 18-21. Medica 2009 is comprised of more than 135,000 individuals, representing over 100 countries, that come to learn about current and future trends in both in-patient and out-patient care.

medelita

“As the largest medical trade show of its kind, Medica 2009 is the ideal venue for us to launch a new product line and showcase current Medelita products to an international audience,” said Joe Francisco, chief operating officer, Medelita. “We are extremely pleased to have been selected as one of an esteemed group of companies, to attend this year and showcase our unique lab coats and scrubs.”

Medelita is one of only ten U.S.-based medical supply companies invited to attend Medica 2009 and exhibit with the U.S. Department of Commerce, Office of Textiles and Apparel (OTEXA). In a recent statement, OTEXA reports that the medical textiles segment of the medical sector is experiencing one of the highest expansion rates in the technical textile market. According to recent research, over the next few years the world market for technical textiles and industrial nonwovens will increase by 3.8% per year – a volume value of nearly $126 billion.

In a bid to capture its share of this growing market, Medelita will be exhibiting its innovative medical apparel at the OTEXA USA Sample Pavilion. The company plans to introduce its men’s line of lab coats at Medica 2009. Medelita products are available direct to consumers and through its retail channels. Wholesale orders also are available to hospitals and large groups.

Made f r o m 100 percent high-denier cotton, the Medelita lab coat is designed specifically for women with a focus on fit and function. The fluid resistant lab coats are treated with Advanced Dual Action Teflon® fabric protector, which allows fabric to repel and release stains. Tailored for a feminine shape, the coats feature traditional side slits, French finish inside seams and hidden inside pockets that are great for carrying handheld devices and mobile phones.

In addition to high quality lab coats, Medelita provides a line of performance women’s healthcare apparel, including clinician scrubs and nursing scrubs, which are available for purchase at www.medelita.com.

Medelita will be exhibiting at the USA Business Information Office, set up by OTEXA, E10, Hall 16. To schedule a SKYPE pre-briefing, please email joe@medelita.com or call 1-877-987-7979.

About Medelita
Medelita has one purpose: to reinvent the way women of all healthcare professions present themselves at work by offering the highest quality, best fitting, and most comfortable medical apparel available, including lab coats, women’s lab coats and women’s scrubs. Medelita caters to professional women who want their uniforms to embody the poise and confidence already displayed f r o m within. For more information, visit our website at http://www.medelita.com or call (877) 987-7979.

Via EPR Network
More Healthcare press releases

Three Alternative Scenarios of the Future In Vitro Diagnostics Market, 2009-2018

Venture Planning Group is pleased to announce completion of the new multiclient study, “Three Alternative Scenarios of the Future In Vitro Diagnostics Market, 2009-2018.” The report is designed to assist executives in the diagnostics industry in formulating policy alternatives that will provide the best choice among possible courses of action.

Venture Planning Group

The major thrust of the study is to clarify future consequences of the current developments in the absence of unforeseeable events, and expose the very different actions and policies that would be required by diagnostic product suppliers if the market moves in any of the three directions.

Each scenario is built around a specific theme with a particular set of assumptions. Business-As-Usual Scenario assumes that the current trends will continue without significant interruptions. Economic Austerity Scenario is predicated upon a significant rise in cost-containment pressures by all payers determined to drastically curtail not only the intensity of health care services, but the size of the industry as well. Technological Breakthroughs Scenario assumes a series of successful developments and commercialization of a number of diagnostic technologies and products occurring during 2009-2018.

This study will help diagnostics industry executives and companies planning to diversify into the diagnostics field to bring about more flexible planning, reduce surprises, and add to ways of improving the ability to cope with the future.

Please visit www.vpgcorp.com to review this and over 5,000 other innovative market research reports from VPG and other world’s leading publishing companies.

About VPG
VPG is an international market research, publishing and management consulting firm providing Market Intelligence Surveys, Opportunity Analyses, New Technology/Product Assessments, and Acquisition/Joint Venture Evaluations to corporate executives and key decision-makers in the healthcare, biotechnology, chemical, food and beverage, and electronics industries worldwide.

Via EPR Network
More Healthcare press releases